Literature DB >> 28432590

Pathological analysis of the surgical margins of resected glioblastomas excised using photodynamic visualization with both 5-aminolevulinic acid and fluorescein sodium.

Hirohito Yano1, Noriyuki Nakayama2, Naoyuki Ohe2, Kazuhiro Miwa3, Jun Shinoda4, Toru Iwama2.   

Abstract

During glioma resection, 5-aminolevulinic acid (5-ALA) and fluorescein sodium (Fl-Na) are used for photodynamic tumor visualization. The objective of this study was to evaluate the pathological findings of the boundary zone between the tumor and adjacent normal brain in glioblastoma patients undergoing simultaneous double staining with 5-ALA and Fl-Na during surgery. Eight patients received 5-ALA (20 mg/kg orally) before the induction of general anesthesia, and Fl-Na (20 mg/kg) was administered intravenously before the dural incision was performed. The tumor bulk was removed under the guidance of Fl-Na staining alone using conventional white light. Subsequently, residual tumor was removed under the guidance of both fluorescent agents within functionally safe limits until both were visibly undetectable. Twenty specimens exhibiting different staining intensities of both agents were obtained. The vessel index (VI) was calculated from CD31 immunohistochemistry (IHC) samples. Boundary zone tumor cells were detected by IHC for olig2, and were expressed as the olig2 index (OLI). The VI was significantly higher in Fl-Na-positive areas than in Fl-Na-negative areas (p = 0.0005). In contrast, the OLI was significantly higher in 5-ALA-positive areas than in 5-ALA-negative areas (p = 0.0149). 5-ALA-positive/Fl-Na negative areas were observed in 7 patients. These findings indicate that Fl-Na accumulates in areas with a disrupted blood-brain barrier, and that 5-ALA fluorescence is dependent on tumor cell protoporphyrin IX metabolism. In conclusion, 5-ALA was better for detecting tumor cells in the boundary zone than was Fl-Na. Of note, tumor cells existed outside the fluorescence-stained boundaries of both agents.

Entities:  

Keywords:  5-Aminolevulinic acid; CD31; Fluorescein sodium; Glioblastoma; Ki-67; Olig2

Mesh:

Substances:

Year:  2017        PMID: 28432590     DOI: 10.1007/s11060-017-2445-5

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  29 in total

1.  Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence.

Authors:  W Stummer; S Stocker; S Wagner; H Stepp; C Fritsch; C Goetz; A E Goetz; R Kiefmann; H J Reulen
Journal:  Neurosurgery       Date:  1998-03       Impact factor: 4.654

2.  Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial.

Authors:  Walter Stummer; Uwe Pichlmeier; Thomas Meinel; Otmar Dieter Wiestler; Friedhelm Zanella; Hans-Jürgen Reulen
Journal:  Lancet Oncol       Date:  2006-05       Impact factor: 41.316

3.  Pathological characterization of the glioblastoma border as shown during surgery using 5-aminolevulinic acid-induced fluorescence.

Authors:  Miguel Angel Idoate; Ricardo Díez Valle; Jose Echeveste; Sonia Tejada
Journal:  Neuropathology       Date:  2011-03-01       Impact factor: 1.906

4.  Surgery guided by 5-aminolevulinic fluorescence in glioblastoma: volumetric analysis of extent of resection in single-center experience.

Authors:  Ricardo Díez Valle; Sonia Tejada Solis; Miguel Angel Idoate Gastearena; Reyes García de Eulate; Pablo Domínguez Echávarri; Javier Aristu Mendiroz
Journal:  J Neurooncol       Date:  2010-07-06       Impact factor: 4.130

5.  Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma.

Authors:  Keith L Ligon; Emmanuelle Huillard; Shwetal Mehta; Santosh Kesari; Hongye Liu; John A Alberta; Robert M Bachoo; Michael Kane; David N Louis; Ronald A Depinho; David J Anderson; Charles D Stiles; David H Rowitch
Journal:  Neuron       Date:  2007-02-15       Impact factor: 17.173

6.  Use of intraoperative fluorescein sodium fluorescence to improve the accuracy of tissue diagnosis during stereotactic needle biopsy of high-grade gliomas.

Authors:  Roberto Rey-Dios; Eyas M Hattab; Aaron A Cohen-Gadol
Journal:  Acta Neurochir (Wien)       Date:  2014-04-27       Impact factor: 2.216

7.  The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas.

Authors:  Keith L Ligon; John A Alberta; Alvin T Kho; Jennifer Weiss; Mary R Kwaan; Catherine L Nutt; David N Louis; Charles D Stiles; David H Rowitch
Journal:  J Neuropathol Exp Neurol       Date:  2004-05       Impact factor: 3.685

Review 8.  [Surgery of high-grade gliomas guided by fluorescence: a retrospective study of 22 patients].

Authors:  T Jacquesson; F Ducray; D Maucort-Boulch; X Armoiry; G Louis-Tisserand; M Mbaye; I Pelissou-Guyotat; J Guyotat
Journal:  Neurochirurgie       Date:  2013-01-12       Impact factor: 1.553

9.  Fluorescence-guided resection of glioblastoma multiforme by using high-dose fluorescein sodium. Technical note.

Authors:  Jun Shinoda; Hirohito Yano; Shin-Ichi Yoshimura; Ayumi Okumura; Yasuhiko Kaku; Toru Iwama; Noboru Sakai
Journal:  J Neurosurg       Date:  2003-09       Impact factor: 5.115

Review 10.  Aminolevulinic acid (ALA)-protoporphyrin IX fluorescence guided tumour resection. Part 1: Clinical, radiological and pathological studies.

Authors:  Michael J Colditz; Rosalind L Jeffree
Journal:  J Clin Neurosci       Date:  2012-09-05       Impact factor: 1.961

View more
  8 in total

Review 1.  Vitamin D and Other Differentiation-promoting Agents as Neoadjuvants for Photodynamic Therapy of Cancer.

Authors:  Edward V Maytin; Tayyaba Hasan
Journal:  Photochem Photobiol       Date:  2020-04-15       Impact factor: 3.421

2.  Fluorescence-Guided Surgery in Glioblastoma: 5-ALA, SF or Both? Differences between Fluorescent Dyes in 99 Consecutive Cases.

Authors:  Pietro Zeppa; Raffaele De Marco; Matteo Monticelli; Armando Massara; Andrea Bianconi; Giuseppe Di Perna; Stefania Greco Crasto; Fabio Cofano; Antonio Melcarne; Michele Maria Lanotte; Diego Garbossa
Journal:  Brain Sci       Date:  2022-04-26

3.  Higher Cho/NAA Ratio in Postoperative Peritumoral Edema Zone Is Associated With Earlier Recurrence of Glioblastoma.

Authors:  Yong Cui; Wei Zeng; Haihui Jiang; Xiaohui Ren; Song Lin; Yanzhu Fan; Yapeng Liu; Jizong Zhao
Journal:  Front Neurol       Date:  2020-12-04       Impact factor: 4.003

Review 4.  State-of-the-art imaging for glioma surgery.

Authors:  Niels Verburg; Philip C de Witt Hamer
Journal:  Neurosurg Rev       Date:  2020-06-30       Impact factor: 3.042

Review 5.  Intraoperative MR Imaging during Glioma Resection.

Authors:  Mitsunori Matsumae; Jun Nishiyama; Kagayaki Kuroda
Journal:  Magn Reson Med Sci       Date:  2021-12-09       Impact factor: 2.760

Review 6.  Fluorescence-Guided Surgery for High-Grade Gliomas: State of the Art and New Perspectives.

Authors:  Giuseppe Palmieri; Fabio Cofano; Luca Francesco Salvati; Matteo Monticelli; Pietro Zeppa; Giuseppe Di Perna; Antonio Melcarne; Roberto Altieri; Giuseppe La Rocca; Giovanni Sabatino; Giuseppe Maria Barbagallo; Fulvio Tartara; Francesco Zenga; Diego Garbossa
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec

7.  Multi-Wavelength Fluorescence in Image-Guided Surgery, Clinical Feasibility and Future Perspectives.

Authors:  Florian van Beurden; Danny M van Willigen; Borivoj Vojnovic; Matthias N van Oosterom; Oscar R Brouwer; Henk G van der Poel; Hisataka Kobayashi; Fijs W B van Leeuwen; Tessa Buckle
Journal:  Mol Imaging       Date:  2020 Jan-Dec       Impact factor: 4.488

8.  Multi-wavelength fluorescence imaging with a da Vinci Firefly-a technical look behind the scenes.

Authors:  Philippa Meershoek; Gijs H KleinJan; Danny M van Willigen; Kevin P Bauwens; Silvia J Spa; Florian van Beurden; Erik J van Gennep; Alexandre M Mottrie; Henk G van der Poel; T Buckle; Fijs W B van Leeuwen; Matthias N van Oosterom
Journal:  J Robot Surg       Date:  2020-11-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.